About Preceptis Medical
Preceptis Medical was founded by parents, including a pediatric anesthesiologist, who wanted to design products focused on improving the lives of children. The Hummingbird Device was designed by the team in partnership with leading pediatric ENTs to simplify ear tube procedures and create options for the procedure to be done with less anesthesia.
Our goal is to broaden options available to ENTs and Parents, focusing on the safety and comfort of the child, while reducing health care costs.
Over 1 million children receive ear tubes each year in the United States, making it the most common pediatric procedure and the primary reason for exposure to general anesthesia in children under 3.
Long-term, we also believe the Hummingbird has the potential to impact the lives of children in developing countries. According to the World Health Organization, chronic otitis media is a leading cause of hearing loss for millions of children and adults in developing countries. For patients with limited or no access to antibiotics or surgical placement of ear tubes, the risk of developing permanent hearing loss is significant.
The Hummingbird has been designed to have a positive impact both near and far. Dr. Frank Rimell, Pediatric ENT, Cedars Sinai Medical Center, Medical Director for Preceptis says, “Hearing loss and deafness is a global health crisis, and the WHO estimates that 34 million children worldwide have disabling hearing loss. 75% of hearing loss in children in developing countries is preventable. I believe that the Hummingbird has the potential to make a significant impact in these countries due to the ability to address preventable causes of hearing loss (chronic otitis media) without a traditional operating room and general anesthesia.”
Board of Directors
Connect With Hummingbird!
10900 89th Avenue North, Suite #4, Maple Grove, MN 55369
Indications for Use: The Hummingbird® Tympanostomy Tube System (HTTS) is intended to deliver a tympanostomy tube (also referred to as a ventilation tube) through the tympanic membrane of the patient and is indicated to be used in office settings for children 6-24 months old.